Improved Medically Assisted Procreation (MAP) Monitoring
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Rate of successful tests
研究概览
简要总结
Patient care in Medically Assisted Procreation (MAP) requires a close and regular monitoring of the evolution of the estradiol rate. This monitoring allows the dose and duration of treatment to be accurately adjusted for each woman (every 24 or 48 hours) up to 10 to 15 days of treatment with gonadotrophins. Oestradiol (E2) is secreted by the growing ovarian follicles and reflects their growth and maturity. Its plasma dosage makes it possible to monitor the ovarian response to stimulation.
This monitoring involves several constraints amongst which disruption of work life, stress, fatigue that can alter the response to treatment
详细描述
In order to improve the comfort of patients already under severe stress, simplification of this monitoring is proposed. The development of an immediate-release whole blood test for simplified monitoring of estradiol levels will provide considerable comfort in the management of patients. These patients are subjected to significant emotional and physical stress and the development of this test will reduce the negative consequences that result.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Adult under safeguard of justice, guardianship or curatorship
- •Persons deprived of liberty.
结局指标
主要结局
Rate of successful tests
时间窗: 1 hour
Number of tests yieling a result (whatever the value)
次要结局
- Sensitivity(Through study completion, an average of 1 month)
- Specificity(Through study completion, an average of 1 month)